Urol. praxi, 2015; 16(2): 61-64

Chlamydial infections diagnostics

MUDr.Drahomíra Polcarová1, MUDr.Hana Zákoucká2
1 Klinika léčebné rehabilitace, Fakultní nemocnice Ostrava
2 Státní zdravotní ústav, Oddělení sexuálně přenosných infekcí, Národní referenční laboratoř pro chlamydie, Praha

Chlamydial infections could possibly lead to a serious damage of human´s health. Chlamydia pneumoniae is the most common pathogen

from this genus, causing primarily respiratory tract infections. The highest attention is concentrated to Chlamydia trachomatis. Chlamydia

psittaci infections are also very important and could be very serious. Diagnostic approach, direct or indirect detection, is influenced singnificantly

by clinical manifestation and chlamydial species. Sampling of a biological material for testing and its quality are absolutely essential.

Keywords: chlamydia, PCR, antibodies, chronic problems

Published: May 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Polcarová D, Zákoucká H. Chlamydial infections diagnostics. Urol. praxi. 2015;16(2):61-64.
Download citation

References

  1. Hammerschlag MR. Chlamydial and Gonococcal Infections in Infants and Children. Clinical Infectious Diseases, vol.53, Issue suppl 3, pp. S99-S102.
  2. Ogawa H, Hashiguchi K, Kazuyama Y. Prolonged and recurrent tonsilitis associated with sexually transmitted Chlamydia trachomatis. J Laryngol Otol. 1993; 107(1): 27-29. Go to original source... Go to PubMed...
  3. Berger RE, Alexander ER, Monda GD, Ansell J, McCormick G, Holmes KK. Chlamydia trachomatis as a cause of acute "idiopathic" epididymitis. N Engl J Med 1978; 298: 301-304. Go to original source... Go to PubMed...
  4. Věžník Z, Přinosilová P, Zajícová A. Historie studia chlamydióz na VúVeL Brno. Solen, sborník abstrakt, ISBN 978-80-87327-17-3, s. 6-7.
  5. Ertem E, Dereli D, Serter D. Chlamyda trachomatis in the eyes and sexual partners of women with genital chlamydial infections. Mikrobiyol Bul. 1993; 27(1): 42-45. Go to PubMed...
  6. Stratton CW, Alberts GL, Franke JJ, Mitchel WM. Interstitial cystitis: can Chlamydia pneumoniae be a cause? Infections in Urology, 2003; 16: 19-21.
  7. Andraws R, Berger JS, Brown DL. Effects of antibiotic therapy on outcomes of patiens with coronary artery disease. A meta-analysis of randomized controlled trials. JAMA 2005; 293: 2641-2647. Go to original source... Go to PubMed...
  8. Baker WL, Vouch KA. Azithromycin for secondary prevention of coronary artery disease: A meta-analysis. Am J Health Syst Pharm 2007; 64: 830-836. Go to original source... Go to PubMed...
  9. Hamidreza, H. atherosclerosis Induced by Chlamydophila pneumoniae: A Controversial Theory. Interdiscip. Perspect. Infect. Dis. 2013; 2013: 941392. Go to original source...
  10. Bell TA, Stamm WE, Wang SP, Kuo Ch, Holmes KK, Grayston JT. Chronic Chlamydia trachomatis Infections in infants. JAMA 1992; 267(3): 400-402. Go to original source...
  11. Carter JD, Gérard HC, Espinoza LR, Ricca LR, Valeriano J, Snelgrove J, Oszust C, Vasey FB, Hudson AP. Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum. 2009; 60(5): 1311-1316. Go to original source... Go to PubMed...
  12. Cinotti R, et al. Coughsyncope cause by a possible Chlamydia pneumoniae pneumonia. Rev.Med.Interne. 2009 Jul 6. Go to PubMed...
  13. Bednář M, et al. Lékařská mikrobiologie: Marvil 1996: 325-333.
  14. Votava M, et al. Lékařská mikrobiologie speciální. Neptun 2003: 173-177.
  15. Centers for Disease Control and Prevention. STD guidelines: MMWR 2010;59 No.RR 12.
  16. Dowell SF, et al. Standardizing Chlamydia pneumoniae assays. Clin. Inf. Dis. 2001; 33: 492-503. Go to original source... Go to PubMed...
  17. Mavrogeni S, Spargias C, Bratis C, Kolovou G, Markussis V, Papadopoulous E, Constadoulakis P, Papadimitropoulos M, Douskou M, PavlidesG, Cokkinos D. Myocarditis as a precipitating factor for heart failure: evaluation and 1-year follow-up using cardiovascular magnetic resonance and endomyocardial biopsy. Eur J Heart Fail. 2011; 13(8): 830-837. Go to original source... Go to PubMed...
  18. Falsey AR, Walsh EE. Transmission of Chlamydia pneumoniae.The Journal of inf. dis. 1993; 168: 439-436. Go to original source...
  19. Doporučený postup Společnosti infekčního lékařství ČLS J. E. Purkyně: Chlamydiové infekce - diagnostika a léčba. http://www.infekce.cz/DopChlam12t.htm.
  20. Mandell GL, et al. Principles and practice of infectious diseases 7th edition. Elsevier 2010. Go to original source...
  21. Beutler AM, Hudson AP, Whittum-Hudson JA, Salameh WA, Gerard HC, Branigan PJ, Schumacher HR Jr. Chlamydia trachomatis Can Persist in Joint Tissu After Antibiotik Treatment in Chronic Reiter's Syndrome/Reactive Arthritis. J Clin Rheumatol 1997; 3: 125-130. Go to original source... Go to PubMed...
  22. Dean D, Suchland RJ, Stamm WE. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J Infect Dis. 2000; 182(3): 909-916. Go to original source... Go to PubMed...
  23. Carter JD, Espinoza LR, Inman RD, Sneed KB, Ricca LR, Vasey FB, Valeriano J, Stanich JA, Oszust C, Gerard HC, Hudson AP. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: A double-blind, placebo-controlled, prospective trial. Arthritis Rheum. 2010 May; 62(5): 1298-1307. Go to original source... Go to PubMed...
  24. Honzíková M. Efekt vehikula v léčbě chlamydiových infekcí. Solen, sborník abstrakt ISBN 978-80-87327-17-3, str.11.
  25. Neubauerová T, Bímová A, Klobásová T, Králová M, Macková M, Macek T. Možný význam systémové enzymoterapie při léčbě antibiotiky. Solen, sborník abstrakt ISBN 978-80-8732-17-3, str. 33-34.
  26. Ringel RE, Givner LB, Brenner JI, Huang SW, Wang SP, Grayston JT, Berman MA: Myocarditis as a complication of infantile Chlamydia trachomatis pneumonitis Clinical Pediatrics; Sep 1983; 22(9): 631. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.